Madison Strategic Sector Premium Fund
|
||
COMMON STOCK - 82.7%
|
Shares
|
Value (Note 1)
|
Consumer Discretionary - 8.9%
|
||
Bed Bath & Beyond Inc.*
|
20,000
|
$ 1,260,000
|
Best Buy Co. Inc.
|
110,000
|
1,890,900
|
Kohl's Corp.
|
35,000
|
1,792,700
|
Staples Inc.
|
50,000
|
576,000
|
Target Corp.
|
20,000
|
1,269,400
|
6,789,000
|
||
Energy - 7.3%
|
||
Apache Corp.
|
25,000
|
2,161,750
|
Canadian Natural Resources Ltd.
|
40,000
|
1,231,600
|
Schlumberger Ltd.
|
30,000
|
2,169,900
|
5,563,250
|
||
Financials - 14.7%
|
||
Affiliated Managers Group Inc.*
|
15,000
|
1,845,000
|
Bank of America Corp.
|
199,800
|
1,764,234
|
Goldman Sachs Group Inc.
|
14,000
|
1,591,520
|
JPMorgan Chase & Co.
|
30,400
|
1,230,592
|
Morgan Stanley
|
70,000
|
1,171,800
|
State Street Corp.
|
60,000
|
2,517,600
|
Wells Fargo & Co.
|
30,000
|
1,035,900
|
11,156,646
|
||
Health Care - 25.9%
|
||
Celgene Corp.*
|
25,000
|
1,910,000
|
Community Health Systems Inc.*
|
50,000
|
1,457,000
|
Laboratory Corp. of America Holdings*
|
20,000
|
1,849,400
|
Medtronic Inc.
|
40,000
|
1,724,800
|
Mylan Inc.*
|
100,000
|
2,440,000
|
Pfizer Inc.
|
39,800
|
989,030
|
St Jude Medical Inc.
|
50,000
|
2,106,500
|
Stryker Corp.
|
35,000
|
1,948,100
|
Teva Pharmaceutical Industries Ltd., ADR
|
50,000
|
2,070,500
|
UnitedHealth Group Inc.
|
20,000
|
1,108,200
|
Zimmer Holdings Inc.
|
30,000
|
2,028,600
|
19,632,130
|
||
Industrials - 3.7%
|
||
Jacobs Engineering Group Inc.*
|
30,000
|
1,212,900
|
Norfolk Southern Corp.
|
25,000
|
1,590,750
|
2,803,650
|
||
Information Technology - 20.6%
|
||
Adobe Systems Inc.*
|
20,000
|
649,200
|
Altera Corp.
|
20,000
|
679,700
|
Apple Inc.
|
2,000
|
1,334,520
|
Applied Materials Inc.
|
90,000
|
1,004,850
|
Cisco Systems Inc.
|
120,000
|
2,290,800
|
EMC Corp.*
|
30,000
|
818,100
|
Facebook Inc.*
|
25,000
|
541,250
|
Flextronics International Ltd.*
|
184,900
|
1,109,400
|
FLIR Systems Inc.
|
80,000
|
1,598,000
|
Google Inc.*
|
3,400
|
2,565,300
|
Hewlett-Packard Co.
|
60,000
|
1,023,600
|
Microsoft Corp.
|
20,000
|
595,600
|
Symantec Corp.*
|
80,000
|
1,440,000
|
15,650,320
|
||
Materials - 1.6%
|
||
Freeport-McMoRan Copper & Gold Inc.
|
30,000
|
1,187,400
|
Total Common Stock (Cost $67,443,731)
|
62,782,396
|
|
U.S. GOVERNMENT AND AGENCY OBLIGATIONS -7.9%
|
||
U.S. Treasury Bills - 7.9%
|
||
0.12%, 10/18/12
|
300,000
|
299,983
|
0.12%, 11/15/12
|
2,000,000
|
1,999,697
|
0.13%, 1/10/13
|
625,000
|
624,771
|
0.14%, 2/7/13
|
475,000
|
474,759
|
0.1%, 2/21/13
|
2,630,000
|
2,628,930
|
Total U.S. Government and Agency Obligations
|
6,028,139
|
|
(Cost $6,028,139)
|
||
INVESTMENT COMPANIES - 0.6%
|
||
SPDR S&P MidCap 400 ETF Trust
|
2,500
|
449,800
|
Total Investment Companies (Cost $425,115)
|
||
|
||
Repurchase Agreement - 14.5%
|
||
With U.S. Bank National Association issued 09/28/12 at 0.01%,
|
||
due 10/01/12, collateralized by $11,242,804 in (Fannie Mae
|
||
Pool #695167) due 5/1/33. Proceeds at maturity are 11,022,208
|
||
(Cost $11,022,199)
|
11,022,199
|
|
TOTAL INVESTMENTS - 105.7% (Cost $84,919,184)
|
80,282,534
|
|
NET OTHER ASSETS AND LIABILITIES - (3.5%)
|
(2,653,342)
|
|
TOTAL CALL & PUT OPTIONS WRITTEN - (2.2%)
|
(1,695,225)
|
|
TOTAL ASSETS - 100%
|
$ 75,933,967
|
|
*Non-income producing
|
||
ADR-American Depository Receipt
|
||
ETF-Exchange Traded Fund
|
Contracts
|
||||||||
(100 Shares
|
Expiration
|
Exercise
|
||||||
Call Options Written
|
Per Contract)
|
Date
|
Price
|
Value
|
||||
Adobe Systems Inc.
|
200
|
October 2012
|
35.00
|
$2,200
|
||||
Affiliated Managers Group Inc.
|
100
|
December 2012
|
110.00
|
145,500
|
||||
Altera Corp.
|
200
|
December 2012
|
35.00
|
32,000
|
||||
Apache Corp.
|
50
|
October 2012
|
110.00
|
100
|
||||
Apple Inc.
|
20
|
February 2013
|
700.00
|
75,500
|
||||
Bank of America Corp.
|
500
|
November 2012
|
8.00
|
49,250
|
||||
Bank of America Corp.
|
400
|
November 2012
|
10.00
|
4,600
|
||||
Bed Bath & Beyond Inc.
|
200
|
February 2013
|
62.50
|
93,500
|
||||
Celgene Corp.
|
100
|
January 2013
|
67.50
|
106,750
|
||||
Cisco Systems Inc.
|
300
|
January 2013
|
17.50
|
59,100
|
||||
Community Health Systems Inc.
|
300
|
December 2012
|
24.00
|
168,000
|
||||
EMC Corp.
|
200
|
January 2013
|
26.00
|
50,600
|
||||
Facebook Inc.
|
250
|
December 2012
|
32.00
|
4,375
|
||||
Freeport-McMoRan Copper & Gold Inc.
|
150
|
November 2012
|
36.00
|
61,875
|
||||
Hewlett-Packard Co.
|
400
|
November 2012
|
24.00
|
400
|
||||
JPMorgan Chase & Co.
|
200
|
December 2012
|
36.00
|
96,500
|
||||
Kohl's Corp.
|
150
|
January 2013
|
52.50
|
30,750
|
||||
Laboratory Corp. of America Holdings
|
100
|
November 2012
|
90.00
|
40,500
|
||||
Medtronic Inc.
|
150
|
January 2013
|
39.00
|
67,500
|
||||
Microsoft Corp.
|
200
|
October 2012
|
33.00
|
700
|
||||
Mylan Inc.
|
300
|
October 2012
|
24.00
|
19,200
|
||||
Norfolk Southern Corp.
|
200
|
December 2012
|
70.00
|
10,000
|
||||
St Jude Medical Inc.
|
250
|
October 2012
|
42.50
|
22,500
|
||||
Stryker Corp.
|
150
|
December 2012
|
55.00
|
36,750
|
||||
Symantec Corp.
|
300
|
October 2012
|
18.00
|
12,900
|
||||
Target Corp.
|
200
|
October 2012
|
57.50
|
121,000
|
||||
Wells Fargo & Co.
|
150
|
October 2012
|
33.00
|
27,375
|
||||
Total Call Options Written (Premiums received $1,352,407)
|
$1,339,425
|
|||||||
Put Options Written
|
||||||||
Apple Inc
|
20
|
February 2013
|
675.00
|
116,850
|
||||
Bed Bath & Beyond Inc
|
200
|
February 2013
|
57.50
|
44,500
|
||||
EMC Corp
|
200
|
January 2013
|
23.00
|
10,000
|
||||
Facebook Inc
|
250
|
December 2012
|
27.00
|
151,250
|
||||
Microsoft Corp
|
200
|
October 2012
|
31.00
|
28,700
|
||||
Symantec Corp
|
300
|
October 2012
|
17.00
|
4,500
|
||||
Total Put Options Written (Premiums received $344,851)
|
$ 355,800
|
|||||||
Total Value Options Written (Premiums received $1,697,258)
|
$ 1,695,225
|
1. Portfolio Valuation: Securities traded on a national securities exchange are valued at their closing sale price except for securities traded on NASDAQ which are valued at the NASDAQ official closing price ("NOCP") and options which are valued at the mean between the best bid and best ask price across all option exchanges. Repurchase agreements and other securities having maturities of 60 days or less are valued at amortized cost, which approximates market value. Securities having longer maturities, for which quotations are readily available, are valued at the mean between their closing bid and ask prices. Securities for which market quotations are not readily available are valued at their fair value as determined in good faith under procedures approved by the Board of Trustees.
|
The Fund has adopted Financial Accounting Standards Board (“FASB”) applicable guidance on fair value measurements. Fair value is defined as the price that each fund would receive upon selling an investment in a timely transaction to an independent buyer in the principal or most advantageous market of the investment. A three-tier hierarchy is used to maximize the use of observable market data “inputs” and minimize the use of unobservable “inputs” and to establish classification of fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability, including assumptions about risk (for example, the risk inherent in a particular valuation technique used to measure fair value including such a pricing model and/or the risk inherent in the inputs to the valuation technique). Inputs may be observable or unobservable. Observable inputs are inputs that reflect the assumptions market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs are inputs that reflect the reporting entity’s own assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The three-tier hierarchy of inputs is summarized in the three broad Levels listed below:
|
Level 1 – unadjusted quoted prices in active markets for identical investments
|
Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rate volatilities, prepayment speeds, credit risk, benchmark yields, transactions, bids, offers, new issues, spreads and other relationships observed in the markets among comparable securities, underlying equity of the issuer; and proprietary pricing models such as yield measures calculated using factors such as cash flows, financial or collateral performance and other reference data, etc.)
|
Level 3 - significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments)
|
The valuation techniques used by the Fund to measure fair value for the period ended September 30, 2012 maximized the use of observable inputs and minimized the use of unobservable inputs. As of September 30, 2012, the Fund held no securities deemed as a Level 3.
|
The following is a summary of the inputs used as of September 30, 2012 in valuing the Fund's investments carried at fair value:
|
Value at
|
||||
Fund
|
(Level 1)
|
(Level 2)
|
(Level 3)
|
9/30/2012
|
Madison Strategic Sector Premium Fund
|
||||
Assets:
|
||||
Common Stocks
|
$ 62,782,396
|
$ -
|
$ -
|
$ 62,782,396
|
Investment Companies
|
449,800
|
449,800
|
||
U.S. Government and Agency Obligations
|
6,028,139
|
6,028,139
|
||
Repurchase Agreement
|
11,022,199
|
11,022,199
|
||
$ 63,232,196
|
$ 17,050,338
|
$ -
|
$ 80,282,534
|
|
Liabilities:
|
||||
Written Options
|
$ 1,695,225
|
$ -
|
$ -
|
$ 1,695,225
|
$ 1,695,225
|
$ -
|
$ -
|
$ 1,695,225
|
The fund adopted guidance on enhanced disclosures about a fund's derivative and hedging activities in order to enable investors to understand: a) how and why a fund uses derivative investments, b) how derivative instruments and related hedge fund items are accounted for, and c) how derivative instruments and related hedge fund items affect a fund’s financial position, results of operations and cash flows
|
The following table presents the types of derivatives in the Fund and their effect:
|
Asset Derivatives
|
Liability Derivatives
|
|||
Derivatives not accounted
|
Fair Value
|
Derivatives not accounted
|
Fair Value
|
|
for as hedging instruments
|
for as hedging instruments
|
|||
Equity contracts
|
$-
|
Options Written
|
$1,695,225
|
In May 2011, FASB issued ASU 2011-04, modifying Topic 820, Fair Value Measurements and Disclosures. At the same time, the International Accounting Standards Board (“IASB”) issued International Financial Reporting Standard (“IFRS”) 13, Fair Value Measurement. The objective by the FASB and IASB is convergence of their guidance on fair value measurements and disclosures. The effective date of the ASU is for Interim and annual periods beginning after December 15, 2011. The Fund has adopted the disclosure required by this update.
|
In December 2011, the International Accounting Standards Board (IASB) and the FASB issued ASU 2011-11 “Disclosures about Offsetting Assets and Liabilities.” These common disclosure requirements are intended to help investors and other financial statement users to better assess the effect or potential effect of offsetting arrangements on a portfolio’s financial position. They also improve transparency in the reporting of how companies mitigate credit risk, including disclosure of related collateral pledged or received. In addition, ASU 2011-11 facilitates comparison between those entities that prepare their financial statements on the basis of U.S. GAAP and those entities that prepare their financial statements on the basis of IFRS. ASU 2011-11 requires entities to disclose both gross and net information about both instruments and transactions eligible for offset in the financial position; and disclose instruments and transactions subject to an agreement similar to a master netting agreement. ASU 2011-11 is effective for fiscal years beginning on or after January 1, 2013, and interim periods within those annual periods. The Investment Adviser is currently evaluating the implications of ASU 2011-11 and its impact on financial statements disclosures.
|
Investment Transactions: Investment transactions are recorded on a trade date basis. The cost of investments sold is determined on the identified cost basis for financial statement and federal income tax purposes.
|